Glioblastomas: whats new?

Stefania Cuzzubbo1, Antoine F Carpentier1

  • 1Service de neurologie, hôpital Avicenne, AP-HP, UFR de santé, médecine et biologie humaine de Bobigny, université Paris 13, Bobigny, France.

La Revue Du Praticien
|December 5, 2018
PubMed

Insights

Glioblastoma treatment combines surgery, radiation, and chemotherapy. Emerging therapies like immunotherapy offer hope for improving outcomes in this aggressive brain cancer.

Area of Science:

  • Neuro-oncology
  • Cancer therapy

Context:

  • Glioblastomas are aggressive brain tumors with a poor prognosis.
  • Current standard treatment involves surgical resection, radiotherapy, and chemotherapy.

Purpose:

  • To review recent advancements in glioblastoma treatment.
  • To highlight novel therapeutic strategies beyond the standard of care.

Summary:

  • Glioblastoma treatment traditionally combines surgery, radiotherapy, and chemotherapy.
  • Emerging approaches include anti-angiogenic agents, electromagnetic fields, and immunotherapy.
  • These novel strategies aim to overcome the limitations of current treatments and improve patient survival.

Impact:

  • Potential to significantly improve the prognosis for glioblastoma patients.
  • Offers new therapeutic avenues for a deadly disease.
  • Provides an overview of cutting-edge research for clinicians and scientists.
Keywords:
glioblastomas